StocksMedium•5 November 2026•
1 min read
Lifecore Biomedical Q1 Results Miss Estimates with $1.08 Loss Per Share
Key Facts
1Lifecore Biomedical reported a GAAP EPS of -$1.08, missing analyst estimates by $0.98.
2The company's revenue came in at $25.3 million, missing expectations by $13.31 million.
Lifecore Biomedical reported a GAAP EPS loss of $1.08 for the fiscal first quarter, missing analyst estimates by $0.98. Seeking Alpha reported that the company's revenue came in at $25.3 million, representing a $13.31 million shortfall against expectations.
LFCR shares closed at $6.44 on November 4, 2026, prior to the release of these results which highlighted a downturn in financial performance. The reporting period saw a revenue gap of over 30% against estimates alongside continued pressure on profitability.